Request Demo
Last update 31 May 2025
MAGE-12 peptide vaccine(National Cancer Institute)
Last update 31 May 2025
Overview
Basic Info
Drug Type Shared antigen vaccine, Synthetic peptide vaccine, Therapeutic vaccine |
Synonyms MAGE-12 |
Target |
Action inhibitors |
Mechanism MAGEA12 inhibitors(MAGE family member A12 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with MAGE-12 peptide vaccine(National Cancer Institute)NCT00020267
Phase I Randomized Study of MAGE-12 Peptide Vaccine in Patients With Refractory Metastatic Cancer Expressing MAGE-12 Antigen
100 Clinical Results associated with MAGE-12 peptide vaccine(National Cancer Institute)
Login to view more data
100 Translational Medicine associated with MAGE-12 peptide vaccine(National Cancer Institute)
Login to view more data
100 Patents (Medical) associated with MAGE-12 peptide vaccine(National Cancer Institute)
Login to view more data
100 Deals associated with MAGE-12 peptide vaccine(National Cancer Institute)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bone Cancer | Phase 1 | United States | 01 Jul 2000 | |
| Breast Cancer | Phase 1 | United States | 01 Jul 2000 | |
| Colonic Cancer | Phase 1 | United States | 01 Jul 2000 | |
| Eye Neoplasms | Phase 1 | United States | 01 Jul 2000 | |
| Lung Cancer | Phase 1 | United States | 01 Jul 2000 | |
| Melanoma, Cutaneous Malignant | Phase 1 | United States | 01 Jul 2000 | |
| Neoplasm Metastasis | Phase 1 | United States | 01 Jul 2000 | |
| Ovarian Carcinosarcoma | Phase 1 | United States | 01 Jul 2000 | |
| Rectal Cancer | Phase 1 | United States | 01 Jul 2000 | |
| Soft Tissue Sarcoma | Phase 1 | United States | 01 Jul 2000 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free